Abstract
Gastrointestinal infections remain a frequent disease worldwide. In order to increase our knowledge of the epidemiology for our patient population, we retrospectively analyzed the results obtained for stool samples received at the clinical microbiology laboratory of the University Hospital of Geneva during a 4-year period. A total of 13,965 specimens from 7,124 patients (1.96 specimens per patient) were cultured, yielding 369 (2.6%) Salmonella spp., 408 (2.9%) Campylobacter spp., and 79 (0.6%) Shigella spp. The cumulative positivity rate of 6.1% decreased to 2.7% when patients received antimicrobial agents (P < 0.001). The positivity rate for 5,912 specimens obtained from patients hospitalized for < or = 3 days was 12.6%, whereas it dropped to 1.4% for patients hospitalized for > 3 days (P < 0.001). Of 3,837 stool samples originating from pediatric patients, 8.8% were positive, and 5.1% of 10,128 samples from adults were positive (P < 0.001). The cytotoxin of Clostridium difficile was detected in 379 of 3,723 samples analyzed (10.2%), and rotaviruses were detected in 190 of 1,601 samples (11.9%). We recommend that the use of cultures for enteric bacterial pathogens be restricted to patients hospitalized for < or = 3 days, with the exceptions of follow-up samples, specimens from immunocompromised patients, and patients whose first sample was culture negative or in the rare event of nosocomial food-borne outbreaks. For patients under antimicrobial therapy, testing for cytotoxin of C. difficile should primarily be requested; this analysis should also be accepted for samples from patients not receiving antimicrobial agents at the time of specimen collection. By applying these restrictions, we could have saved at least $5,000 annually.
Full Text
The Full Text of this article is available as a PDF (164.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adler-Mosca H., Lüthy-Hottenstein J., Martinetti Lucchini G., Burnens A., Altwegg M. Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):953–957. doi: 10.1007/BF02005451. [DOI] [PubMed] [Google Scholar]
- Albrecht H., Stellbrink H. J., Fenske S., Ermer M., Raedler A., Greten H. Rotavirus antigen detection in patients with HIV infection and diarrhea. Scand J Gastroenterol. 1993 Apr;28(4):307–310. doi: 10.3109/00365529309090246. [DOI] [PubMed] [Google Scholar]
- Allos B. M., Blaser M. J. Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis. 1995 May;20(5):1092–1101. doi: 10.1093/clinids/20.5.1092. [DOI] [PubMed] [Google Scholar]
- Aserkoff B., Bennett J. V. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N Engl J Med. 1969 Sep 18;281(12):636–640. doi: 10.1056/NEJM196909182811202. [DOI] [PubMed] [Google Scholar]
- Ashkenazi S., Pickering L. K. New causes of infectious diarrhea. Eur J Clin Microbiol Infect Dis. 1991 Jan;10(1):1–3. doi: 10.1007/BF01967088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barbut F., Leluan P., Antoniotti G., Collignon A., Sédallian A., Petit J. C. Value of routine stool cultures in hospitalized patients with diarrhea. Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):346–349. doi: 10.1007/BF02116530. [DOI] [PubMed] [Google Scholar]
- Bern C., Martines J., de Zoysa I., Glass R. I. The magnitude of the global problem of diarrhoeal disease: a ten-year update. Bull World Health Organ. 1992;70(6):705–714. [PMC free article] [PubMed] [Google Scholar]
- Carbon C., Richard A., Bons B. Les colites pseudo-membraneuses associées à l'antibiothérapie. Résultats d'une enquête auprès de 900 gastroentérologues. Therapie. 1994 Jul-Aug;49(4):325–331. [PubMed] [Google Scholar]
- Ehrich M., Van Tassell R. L., Libby J. M., Wilkins T. D. Production of Clostridium difficile antitoxin. Infect Immun. 1980 Jun;28(3):1041–1043. doi: 10.1128/iai.28.3.1041-1043.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fan K., Morris A. J., Reller L. B. Application of rejection criteria for stool cultures for bacterial enteric pathogens. J Clin Microbiol. 1993 Aug;31(8):2233–2235. doi: 10.1128/jcm.31.8.2233-2235.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guerrant R. L., Hughes J. M., Lima N. L., Crane J. Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis. 1990 Jan-Feb;12 (Suppl 1):S41–S50. doi: 10.1093/clinids/12.Supplement_1.S41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haffejee I. E. The epidemiology of rotavirus infections: a global perspective. J Pediatr Gastroenterol Nutr. 1995 Apr;20(3):275–286. doi: 10.1097/00005176-199504000-00003. [DOI] [PubMed] [Google Scholar]
- Hirschhorn L. R., Trnka Y., Onderdonk A., Lee M. L., Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis. 1994 Jan;169(1):127–133. doi: 10.1093/infdis/169.1.127. [DOI] [PubMed] [Google Scholar]
- Knoop F. C., Owens M., Crocker I. C. Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev. 1993 Jul;6(3):251–265. doi: 10.1128/cmr.6.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lüscher D., Altwegg M. Detection of shigellae, enteroinvasive and enterotoxigenic Escherichia coli using the polymerase chain reaction (PCR) in patients returning from tropical countries. Mol Cell Probes. 1994 Aug;8(4):285–290. doi: 10.1006/mcpr.1994.1040. [DOI] [PubMed] [Google Scholar]
- Morris A. J., Murray P. R., Reller L. B. Contemporary testing for enteric pathogens: the potential for cost, time, and health care savings. J Clin Microbiol. 1996 Jul;34(7):1776–1778. doi: 10.1128/jcm.34.7.1776-1778.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Portnoy D., Soneji A., Murray D., Richards G. K. Pseudomembranous colitis: multiple relapses after treatment with metronidazole. Can Med Assoc J. 1981 Jun 15;124(12):1603–1605. [PMC free article] [PubMed] [Google Scholar]
- Rohner P., Dharan S., Auckenthaler R. Evaluation of the Wellcolex Colour Salmonella Test for detection of Salmonella spp. in enrichment broths. J Clin Microbiol. 1992 Dec;30(12):3274–3276. doi: 10.1128/jcm.30.12.3274-3276.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Siegel D. L., Edelstein P. H., Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA. 1990 Feb 16;263(7):979–982. [PubMed] [Google Scholar]
- Steel H. M., Garnham S., Beards G. M., Brown D. W. Investigation of an outbreak of rotavirus infection in geriatric patients by serotyping and polyacrylamide gel electrophoresis (PAGE). J Med Virol. 1992 Jun;37(2):132–136. doi: 10.1002/jmv.1890370211. [DOI] [PubMed] [Google Scholar]
- Teasley D. G., Gerding D. N., Olson M. M., Peterson L. R., Gebhard R. L., Schwartz M. J., Lee J. T., Jr Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet. 1983 Nov 5;2(8358):1043–1046. doi: 10.1016/s0140-6736(83)91036-x. [DOI] [PubMed] [Google Scholar]
- Telzak E. E., Budnick L. D., Greenberg M. S., Blum S., Shayegani M., Benson C. E., Schultz S. A nosocomial outbreak of Salmonella enteritidis infection due to the consumption of raw eggs. N Engl J Med. 1990 Aug 9;323(6):394–397. doi: 10.1056/NEJM199008093230607. [DOI] [PubMed] [Google Scholar]
- Valenstein P., Pfaller M., Yungbluth M. The use and abuse of routine stool microbiology: a College of American Pathologists Q-probes study of 601 institutions. Arch Pathol Lab Med. 1996 Feb;120(2):206–211. [PubMed] [Google Scholar]
- Wilcox M. H., Howe R. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. J Antimicrob Chemother. 1995 Oct;36(4):673–679. doi: 10.1093/jac/36.4.673. [DOI] [PubMed] [Google Scholar]
- Wiström J., Norrby S. R. Fluoroquinolones and bacterial enteritis, when and for whom? J Antimicrob Chemother. 1995 Jul;36(1):23–39. doi: 10.1093/jac/36.1.23. [DOI] [PubMed] [Google Scholar]